Smad2 Is Essential for Maintenance of the Human and Mouse Primed Pluripotent Stem Cell State*

Background: TGF-β signaling is required for primed pluripotency, but the roles of Smad2 and Smad3 have not been well defined. Results: Smad2, but not Smad3, has a role in pluripotency by activating Nanog expression and repressing BMP signaling. Conclusion: Smad2 is essential in the maintenance of pluripotency. Significance: The roles of Smad2 and Smad3 need to be distinguished in the regulation of pluripotency by TGF-β signaling. Human embryonic stem cells and mouse epiblast stem cells represent a primed pluripotent stem cell state that requires TGF-β/activin signaling. TGF-β and/or activin are commonly thought to regulate transcription through both Smad2 and Smad3. However, the different contributions of these two Smads to primed pluripotency and the downstream events that they may regulate remain poorly understood. We addressed the individual roles of Smad2 and Smad3 in the maintenance of primed pluripotency. We found that Smad2, but not Smad3, is required to maintain the undifferentiated pluripotent state. We defined a Smad2 regulatory circuit in human embryonic stem cells and mouse epiblast stem cells, in which Smad2 acts through binding to regulatory promoter sequences to activate Nanog expression while in parallel repressing autocrine bone morphogenetic protein signaling. Increased autocrine bone morphogenetic protein signaling caused by Smad2 down-regulation leads to cell differentiation toward the trophectoderm, mesoderm, and germ cell lineages. Additionally, induction of Cdx2 expression, as a result of decreased Smad2 expression, leads to repression of Oct4 expression, which, together with the decreased Nanog expression, accelerates the loss of pluripotency. These findings reveal that Smad2 is a unique integrator of transcription and signaling events and is essential for the maintenance of the mouse and human primed pluripotent stem cell state.

[1]  N. Nakatsuji,et al.  The SMAD2/3 corepressor SNON maintains pluripotency through selective repression of mesendodermal genes in human ES cells. , 2012, Genes & development.

[2]  D. Huylebroeck,et al.  Antagonism of Nodal signaling by BMP/Smad5 prevents ectopic primitive streak formation in the mouse amnion , 2012, Development.

[3]  G. Blin,et al.  The developmental dismantling of pluripotency is reversed by ectopic Oct4 expression , 2012, Development.

[4]  R. Randall,et al.  Transforming Growth Factor (cid:1) Inhibits Bone Morphogenetic Protein-Induced Transcription through Novel Phosphorylated Smad1/5-Smad3 Complexes , 2022 .

[5]  M. O’Connor,et al.  R-Smad Competition Controls Activin Receptor Output in Drosophila , 2012, PloS one.

[6]  David M Reynolds,et al.  Signaling network crosstalk in human pluripotent cells: a Smad2/3-regulated switch that controls the balance between self-renewal and differentiation. , 2012, Cell stem cell.

[7]  M. Araúzo-Bravo,et al.  FGF signalling inhibits neural induction in human embryonic stem cells , 2011, The EMBO journal.

[8]  François Gerbe,et al.  Primitive endoderm differentiates via a three-step mechanism involving Nanog and RTK signaling. , 2011, Developmental cell.

[9]  David A. Orlando,et al.  Master Transcription Factors Determine Cell-Type-Specific Responses to TGF-β Signaling , 2011, Cell.

[10]  K. Niakan,et al.  BRACHYURY and CDX2 Mediate BMP-Induced Differentiation of Human and Mouse Pluripotent Stem Cells into Embryonic and Extraembryonic Lineages , 2011, Cell stem cell.

[11]  G. Pan,et al.  FGF2 sustains NANOG and switches the outcome of BMP4-induced human embryonic stem cell differentiation. , 2011, Cell stem cell.

[12]  R. Kemler,et al.  Nanog is required for primitive endoderm formation through a non-cell autonomous mechanism. , 2010, Developmental biology.

[13]  P. Andrews,et al.  The Role of SMAD4 in Human Embryonic Stem Cell Self‐Renewal and Stem Cell Fate , 2010, Stem cells.

[14]  T. Magnuson,et al.  Nodal Signaling Regulates the Bone Morphogenic Protein Pluripotency Pathway in Mouse Embryonic Stem Cells* , 2010, The Journal of Biological Chemistry.

[15]  S. Chandran,et al.  Activin/Nodal Inhibition Alone Accelerates Highly Efficient Neural Conversion from Human Embryonic Stem Cells and Imposes a Caudal Positional Identity , 2009, PloS one.

[16]  Ge Guo,et al.  Nanog Is the Gateway to the Pluripotent Ground State , 2009, Cell.

[17]  Chi-Wei Lu,et al.  Cross-regulation of the Nanog and Cdx2 promoters , 2009, Cell Research.

[18]  J. Nichols,et al.  Naive and primed pluripotent states. , 2009, Cell stem cell.

[19]  H. Ohta,et al.  A Signaling Principle for the Specification of the Germ Cell Lineage in Mice , 2009, Cell.

[20]  M. Trotter,et al.  Activin/Nodal signalling maintains pluripotency by controlling Nanog expression , 2009, Development.

[21]  K. Miyazono,et al.  Antagonism between Smad1 and Smad2 signaling determines the site of distal visceral endoderm formation in the mouse embryo , 2009, The Journal of cell biology.

[22]  Milena B. Furtado,et al.  BMP/SMAD1 signaling sets a threshold for the left/right pathway in lateral plate mesoderm and limits availability of SMAD4. , 2008, Genes & development.

[23]  Norio Nakatsuji,et al.  Defining early lineage specification of human embryonic stem cells by the orchestrated balance of canonical Wnt/β-catenin, Activin/Nodal and BMP signaling , 2008, Development.

[24]  G. Pan,et al.  NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs. , 2008, Cell stem cell.

[25]  J. Vaughan,et al.  A Smad-binding Element in Intron 1 Participates in Activin-dependent Regulation of the Follistatin Gene* , 2008, Journal of Biological Chemistry.

[26]  Lin Chen,et al.  Short-term BMP-4 treatment initiates mesoderm induction in human embryonic stem cells. , 2008, Blood.

[27]  J. Nichols,et al.  Nanog safeguards pluripotency and mediates germline development , 2007, Nature.

[28]  Takashi Hiiragi,et al.  Stochastic patterning in the mouse pre-implantation embryo , 2007, Development.

[29]  N. Terada,et al.  A Heterogeneous Expression Pattern for Nanog in Embryonic Stem Cells , 2007, Stem cells.

[30]  Sean C. Bendall,et al.  IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro , 2007, Nature.

[31]  R. McKay,et al.  New cell lines from mouse epiblast share defining features with human embryonic stem cells , 2007, Nature.

[32]  M. Trotter,et al.  Derivation of pluripotent epiblast stem cells from mammalian embryos , 2007, Nature.

[33]  Alexei A. Sharov,et al.  Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells , 2007, Nature Cell Biology.

[34]  A. Clark,et al.  Bone morphogenetic proteins induce germ cell differentiation from human embryonic stem cells. , 2006, Stem cells and development.

[35]  Fred H. Gage,et al.  Nanog binds to Smad1 and blocks bone morphogenetic protein-induced differentiation of embryonic stem cells , 2006, Proceedings of the National Academy of Sciences.

[36]  D. Scadden,et al.  The stem-cell niche as an entity of action , 2006, Nature.

[37]  Xuan Yuan,et al.  Activin A Maintains Self‐Renewal and Regulates Fibroblast Growth Factor, Wnt, and Bone Morphogenic Protein Pathways in Human Embryonic Stem Cells , 2006, Stem cells.

[38]  Yoav Mayshar,et al.  Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features , 2006, Development.

[39]  X. Chen,et al.  The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells , 2006, Nature Genetics.

[40]  Janet Rossant,et al.  Interaction between Oct3/4 and Cdx2 Determines Trophectoderm Differentiation , 2005, Cell.

[41]  J. Massagué,et al.  Smad transcription factors. , 2005, Genes & development.

[42]  H. Schöler,et al.  Developmental cell biology: Regulatory networks in embryo-derived pluripotent stem cells , 2005, Nature Reviews Molecular Cell Biology.

[43]  R. Derynck,et al.  SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS , 2005 .

[44]  R. Pedersen,et al.  Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells , 2005, Journal of Cell Science.

[45]  Megan F. Cole,et al.  Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells , 2005, Cell.

[46]  P. Robson,et al.  Transcriptional Regulation of Nanog by OCT4 and SOX2* , 2005, Journal of Biological Chemistry.

[47]  K. Miyazono,et al.  BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. , 2005, Cytokine & growth factor reviews.

[48]  Janet Rossant,et al.  Cdx2 is required for correct cell fate specification and differentiation of trophectoderm in the mouse blastocyst , 2005, Development.

[49]  Ana D. Lopez,et al.  Activin A Maintains Pluripotency of Human Embryonic Stem Cells in the Absence of Feeder Layers , 2005, Stem cells.

[50]  Ariel J. Levine,et al.  TGFβ/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells , 2005 .

[51]  M. Tada,et al.  Octamer and Sox Elements Are Required for Transcriptional cis Regulation of Nanog Gene Expression , 2005, Molecular and Cellular Biology.

[52]  Motoki Saito,et al.  Oct-3/4 and Sox2 Regulate Oct-3/4 Gene in Embryonic Stem Cells* , 2005, Journal of Biological Chemistry.

[53]  R. Derynck,et al.  TGF‐β‐activated Smad3 represses MEF2‐dependent transcription in myogenic differentiation , 2004, The EMBO journal.

[54]  M. Murakami,et al.  The Homeoprotein Nanog Is Required for Maintenance of Pluripotency in Mouse Epiblast and ES Cells , 2003, Cell.

[55]  J. Nichols,et al.  Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells , 2003, Cell.

[56]  J. Thomson,et al.  BMP4 initiates human embryonic stem cell differentiation to trophoblast , 2002, Nature Biotechnology.

[57]  C. Hill,et al.  Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. , 2002, Molecular cell.

[58]  R. Derynck,et al.  TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. , 2001, Genes & development.

[59]  D. He,et al.  Transforming growth factor beta -inducible independent binding of SMAD to the Smad7 promoter. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[60]  R. Derynck,et al.  Roles of Autocrine TGF-β Receptor and Smad Signaling in Adipocyte Differentiation , 2000, The Journal of cell biology.

[61]  F M Watt,et al.  Out of Eden: stem cells and their niches. , 2000, Science.

[62]  J. Gauthier,et al.  A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3 , 1999, Oncogene.

[63]  Yigong Shi,et al.  Crystal Structure of a Smad MH1 Domain Bound to DNA Insights on DNA Binding in TGF-β Signaling , 1998, Cell.

[64]  J. Massagué,et al.  Physical and Functional Interaction of SMADs and p300/CBP* , 1998, The Journal of Biological Chemistry.

[65]  J. D. Brown,et al.  CREB binding protein is a required coactivator for Smad-dependent, transforming growth factor beta transcriptional responses in endothelial cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[66]  R. Derynck,et al.  The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation. , 1998, Genes & development.

[67]  T. Hunter,et al.  TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300. , 1998, Genes & development.

[68]  P. Hoodless,et al.  Smad2 Signaling in Extraembryonic Tissues Determines Anterior-Posterior Polarity of the Early Mouse Embryo , 1998, Cell.

[69]  J. Massagué,et al.  Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways , 1996, Nature.

[70]  W. Harris,et al.  Inhibition of Activin/Nodal signaling promotes specification of human embryonic stem cells into neuroectoderm. , 2008, Developmental biology.

[71]  A. Hampl,et al.  Comparative study of mouse and human feeder cells for human embryonic stem cells. , 2008, The International journal of developmental biology.

[72]  八木 健,et al.  Alternatively spliced variant of smad2 lacking exon 3 : comparison with wild-type smad2 and smad3 , 2001 .